7240999

CDNF Monoclonal Antibody (D2), Invitrogen™

Mouse Monoclonal Antibody

Manufacturer: Fischer Scientific

The price for this product is unavailable. Please request a quote

Antigen

CDNF

Concentration

1 mg/mL

Classification

Monoclonal

Form

Liquid

Regulatory Status

RUO

Formulation

PBS with 50% glycerol and 0.05% ProClin 300

Gene Alias

9330140G23; arginine-rich protein mutated in early stage tumors-like 1; arginine-rich, mutated in early stage tumors-like 1; ARMETL1; ARMET-like protein 1; Cdnf; Cerebral dopamine neurotrophic factor; conserved dopamine neurotrophic factor

Gene Symbols

Cdnf

Isotype

IgG2b κ

Purification Method

Protein A/G

Product Type

Antibody

Clone

D2

Applications

Immunohistochemistry (Paraffin), Western Blot

Conjugate

Unconjugated

Host Species

Mouse

Target Species

Human

Gene Accession No.

Q49AH0

Gene ID (Entrez)

441549

Immunogen

Pro33-Leu187 (Accession Q49AH0), with N-terminal His and GST Tag

Primary or Secondary

Primary

Content And Storage

-20°C

Gene

Cdnf

Related Products

Img

Fischer Scientific

7240911

Mouse Monoclonal Antibody...

Img

Fischer Scientific

7240911

Mouse Monoclonal Antibody...

Img

Fischer Scientific

7240911

Mouse Monoclonal Antibody...

Img

Fischer Scientific

7240983

Mouse Monoclonal Antibody...

Img

Fischer Scientific

7240914

Mouse Monoclonal Antibody...

Img

Fischer Scientific

7240893

Mouse Monoclonal Antibody...

Img

Fischer Scientific

7240893

Mouse Monoclonal Antibody...

Img

Fischer Scientific

7240802

Mouse Monoclonal Antibody...

Description

  • The conserved dopamine neurotrophic factor (CDNF) is a neurotrophic factor for dopaminergic neurons and highly homologous to the mesencephalic-astrocyte-derived neuro-trophic factor
  • Somewhat surprisingly, CDCF is expressed at higher levels in tissues such as heart, skeletal muscle and testes than in brain
  • Similar to the glial cell line-derived neurotrophic factor (GDNF), CDNF can prevent the 6-hydroxylamine (6 OHDA) induced degeneration of dopaminergic neurons in a rat model of Parkinsons disease
  • Furthermore, CDNF was able to restore the dopaminergic function and prevent the degeneration of dopaminergic neurons in the substantia nigra, suggesting that CDNF might be suitable for the treatment of Parkinsons disease
  • At least two isoforms of CDNF are known to exist.